FIELD: medicine.
SUBSTANCE: invention relates to a compound having a structure: X-Y-Z; where: X is polypeptide at least 80% identical to a sequence with SEQ ID NO: 3; Z is a molecule delivering to bones, containing 4 or more acidic amino acid residues, polyphosphate, aminoadipine acid, alendronate, and/or bisphosphonate; and Y is a linker containing polypeptide at least 80% identical to a sequence with amino acid residues 35-46 of full-sized peptide relative to parathyroid hormone; or its pharmaceutically acceptable salt, as well as to a method for the treatment of bone fracture.
EFFECT: drug delivery system is developed, which corrects some side effects caused by a free anabolic drug, such as high concentration of calcium in blood.
15 cl, 27 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIQUID PHARMACEUTICAL FORMULATIONS OF PTH CONJUGATES | 2020 |
|
RU2817015C2 |
| TREATMENT OF HYPOPARATHYROIDISM | 2021 |
|
RU2827712C1 |
| DOSAGE MODE OF PTH COMPOUND OF CONTROLLED RELEASE | 2017 |
|
RU2777357C2 |
| GIP AGONIST COMPOUNDS AND METHODS | 2015 |
|
RU2716985C2 |
| STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION | 2016 |
|
RU2740672C2 |
| RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THEIR THERAPEUTIC USE | 2018 |
|
RU2811435C2 |
| Cys80-CONJUGATED IMMUNOGLOBULINS | 2016 |
|
RU2756101C2 |
| AMATOXIN ANTIBODY-DRUG CONJUGATES AND USE THEREOF | 2020 |
|
RU2826004C2 |
| ANTIBODIES TARGETING BONE | 2018 |
|
RU2801206C2 |
| MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE FRAGMENTS AND METHODS OF USE THEREOF | 2014 |
|
RU2832636C2 |
